Federated Hermes, Inc. Bridge Bio Pharma, Inc. Transaction History

Federated Hermes, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	SELL	$23.0 - $31.04 $1.73 Million - $2.33 Million	-75,028 Reduced 94.34%	4,500 $113,000
Q1 2024 May 14, 2024	SELL	$27.35 - $40.45 $10.1 Million - $14.9 Million	-367,643 Reduced 82.22%	79,528 $2.46 Million
Q4 2023 Jan 31, 2024	SELL	$24.02 - $43.89 $446,892 - $816,573	-18,605 Reduced 3.99%	447,171 $18.1 Million
Q3 2023 Nov 13, 2023	BUY	$16.89 - $35.01 $538,030 - $1.12 Million	31,855 Added 7.34%	465,776 $12.3 Million
Q2 2023 Aug 14, 2023	BUY	$13.29 - $18.01 $2.37 Million - $3.21 Million	178,353 Added 69.79%	433,921 $7.46 Million
Q1 2023 May 08, 2023	BUY	$7.17 - $18.55 $1.83 Million - $4.74 Million	255,568 New	255,568 $4.24 Million
Q3 2019 Nov 14, 2019	SELL	$20.13 - $32.38 $100,650 - $161,900	-5,000 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$26.97 - $27.55 $134,850 - $137,750	5,000 New	5,000 $135,000

291

171M

10.4M

2.37M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $3.42B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.